Philipp du Cros
- Сўнгги маълум муассаса:
- Médecins Sans Frontières
- ORCID:
- 0000-0002-3599-029X
4
h-индекс
1
i10-индекси
48
Иқтибослар
20
Асарлар
Вақт бўйича
Вақт бўйича таҳлил
Иқтибос шарҳи
Йиллар бўйича нашрлар (устун) ва иқтибослар (чизиқ)
- Нашрлар
- Иқтибослар
Иқтибос тарихи
Нашр тарихи
h-индекс эволюцияси
Йиллар бўйича жамланган h-индекс
Энг кўп иқтибос қилинган асарлар
- Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011201315 иқтибос
- A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis20225 иқтибос
- Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20164 иқтибос
- Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses20174 иқтибос
- Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20163 иқтибос
- ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan20162 иқтибос
- Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?20151 иқтибос
- Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan20181 иқтибос
- Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis20191 иқтибос
- Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan20201 иқтибос